PAR8 TRENDS IN PRESCRIPTION CLAIMS FOLLOWING THE WITHDRAWAL OF ROFECOXIB FROM THE CANADIAN MARKET
Abstract
Authors
O Desjardins J Manley N Nanwa YI Goh RW Smith TR Einarson
O Desjardins J Manley N Nanwa YI Goh RW Smith TR Einarson
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now